Global Cancer Anorexia-Cachexia Syndrome Drug Market Research Report 2023

Report ID: 1969830 | Published Date: Jan 2025 | No. of Page: 98 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Cancer Anorexia-Cachexia Syndrome Drug Market Overview
    1.1 Product Overview and Scope of Cancer Anorexia-Cachexia Syndrome Drug
    1.2 Cancer Anorexia-Cachexia Syndrome Drug Segment by Type
        1.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 NEO-1940
        1.2.3 C-1889
        1.2.4 DLN-101
        1.2.5 Foxo1-nRNA
        1.2.6 AVGN-7
        1.2.7 Others
    1.3 Cancer Anorexia-Cachexia Syndrome Drug Segment by Application
        1.3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Comparison by Application: (2022-2028)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Estimates and Forecasts
        1.4.1 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue 2017-2028
        1.4.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales 2017-2028
        1.4.3 Cancer Anorexia-Cachexia Syndrome Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Cancer Anorexia-Cachexia Syndrome Drug Market Competition by Manufacturers
    2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Cancer Anorexia-Cachexia Syndrome Drug Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Sites, Area Served, Product Type
    2.5 Cancer Anorexia-Cachexia Syndrome Drug Market Competitive Situation and Trends
        2.5.1 Cancer Anorexia-Cachexia Syndrome Drug Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Cancer Anorexia-Cachexia Syndrome Drug Players Market Share by Revenue
        2.5.3 Global Cancer Anorexia-Cachexia Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cancer Anorexia-Cachexia Syndrome Drug Retrospective Market Scenario by Region
    3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Cancer Anorexia-Cachexia Syndrome Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Country
        3.3.1 North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country
        3.3.2 North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Country
        3.4.1 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country
        3.4.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Region
        3.5.1 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Region
        3.5.2 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Country
        3.6.1 Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country
        3.6.2 Latin America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Country
        3.7.1 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country
        3.7.2 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Cancer Anorexia-Cachexia Syndrome Drug Historic Market Analysis by Type
    4.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2017-2022)
    4.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type (2017-2022)
    4.3 Global Cancer Anorexia-Cachexia Syndrome Drug Price by Type (2017-2022)
5 Global Cancer Anorexia-Cachexia Syndrome Drug Historic Market Analysis by Application
    5.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2017-2022)
    5.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application (2017-2022)
    5.3 Global Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Acacia Pharma Ltd
        6.1.1 Acacia Pharma Ltd Corporation Information
        6.1.2 Acacia Pharma Ltd Description and Business Overview
        6.1.3 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
        6.1.5 Acacia Pharma Ltd Recent Developments/Updates
    6.2 Aeterna Zentaris Inc
        6.2.1 Aeterna Zentaris Inc Corporation Information
        6.2.2 Aeterna Zentaris Inc Description and Business Overview
        6.2.3 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
        6.2.5 Aeterna Zentaris Inc Recent Developments/Updates
    6.3 Aphios Corp
        6.3.1 Aphios Corp Corporation Information
        6.3.2 Aphios Corp Description and Business Overview
        6.3.3 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
        6.3.5 Aphios Corp Recent Developments/Updates
    6.4 Incyte Corp
        6.4.1 Incyte Corp Corporation Information
        6.4.2 Incyte Corp Description and Business Overview
        6.4.3 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
        6.4.5 Incyte Corp Recent Developments/Updates
    6.5 Lakewood-Amedex Inc
        6.5.1 Lakewood-Amedex Inc Corporation Information
        6.5.2 Lakewood-Amedex Inc Description and Business Overview
        6.5.3 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
        6.5.5 Lakewood-Amedex Inc Recent Developments/Updates
    6.6 Novartis AG
        6.6.1 Novartis AG Corporation Information
        6.6.2 Novartis AG Description and Business Overview
        6.6.3 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
        6.6.5 Novartis AG Recent Developments/Updates
    6.7 Obexia AG
        6.6.1 Obexia AG Corporation Information
        6.6.2 Obexia AG Description and Business Overview
        6.6.3 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
        6.7.5 Obexia AG Recent Developments/Updates
    6.8 PsiOxus Therapeutics Ltd
        6.8.1 PsiOxus Therapeutics Ltd Corporation Information
        6.8.2 PsiOxus Therapeutics Ltd Description and Business Overview
        6.8.3 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
        6.8.5 PsiOxus Therapeutics Ltd Recent Developments/Updates
    6.9 RaQualia Pharma Inc
        6.9.1 RaQualia Pharma Inc Corporation Information
        6.9.2 RaQualia Pharma Inc Description and Business Overview
        6.9.3 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
        6.9.5 RaQualia Pharma Inc Recent Developments/Updates
    6.10 Viking Therapeutics Inc
        6.10.1 Viking Therapeutics Inc Corporation Information
        6.10.2 Viking Therapeutics Inc Description and Business Overview
        6.10.3 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
        6.10.5 Viking Therapeutics Inc Recent Developments/Updates
7 Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Cost Analysis
    7.1 Cancer Anorexia-Cachexia Syndrome Drug Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Cancer Anorexia-Cachexia Syndrome Drug
    7.4 Cancer Anorexia-Cachexia Syndrome Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Cancer Anorexia-Cachexia Syndrome Drug Distributors List
    8.3 Cancer Anorexia-Cachexia Syndrome Drug Customers
9 Cancer Anorexia-Cachexia Syndrome Drug Market Dynamics
    9.1 Cancer Anorexia-Cachexia Syndrome Drug Industry Trends
    9.2 Cancer Anorexia-Cachexia Syndrome Drug Market Drivers
    9.3 Cancer Anorexia-Cachexia Syndrome Drug Market Challenges
    9.4 Cancer Anorexia-Cachexia Syndrome Drug Market Restraints
10 Global Market Forecast
    10.1 Cancer Anorexia-Cachexia Syndrome Drug Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Cancer Anorexia-Cachexia Syndrome Drug by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Cancer Anorexia-Cachexia Syndrome Drug by Type (2023-2028)
    10.2 Cancer Anorexia-Cachexia Syndrome Drug Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Cancer Anorexia-Cachexia Syndrome Drug by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Cancer Anorexia-Cachexia Syndrome Drug by Application (2023-2028)
    10.3 Cancer Anorexia-Cachexia Syndrome Drug Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Cancer Anorexia-Cachexia Syndrome Drug by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Cancer Anorexia-Cachexia Syndrome Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
    Table 2. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
    Table 3. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Cancer Anorexia-Cachexia Syndrome Drug Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs) of Key Manufacturers (2017-2022)
    Table 6. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Cancer Anorexia-Cachexia Syndrome Drug Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Sites and Area Served
    Table 11. Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Cancer Anorexia-Cachexia Syndrome Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Anorexia-Cachexia Syndrome Drug as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2017-2022) & (K Pcs)
    Table 16. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2017-2022)
    Table 17. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region (2017-2022)
    Table 19. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2017-2022) & (K Pcs)
    Table 20. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2017-2022)
    Table 21. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2017-2022)
    Table 23. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2017-2022) & (K Pcs)
    Table 24. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2017-2022)
    Table 25. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2017-2022) & (K Pcs)
    Table 28. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2017-2022) & (K Pcs)
    Table 32. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2017-2022)
    Table 33. Latin America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2017-2022) & (K Pcs)
    Table 36. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2017-2022)
    Table 39. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
    Table 40. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2017-2022)
    Table 41. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Type (2017-2022)
    Table 43. Global Cancer Anorexia-Cachexia Syndrome Drug Price by Type (2017-2022) & (USD/Pcs)
    Table 44. Global Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs) by Application (2017-2022)
    Table 45. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2017-2022)
    Table 46. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Application (2017-2022)
    Table 48. Global Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2017-2022) & (USD/Pcs)
    Table 49. Acacia Pharma Ltd Corporation Information
    Table 50. Acacia Pharma Ltd Description and Business Overview
    Table 51. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 52. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Product
    Table 53. Acacia Pharma Ltd Recent Developments/Updates
    Table 54. Aeterna Zentaris Inc Corporation Information
    Table 55. Aeterna Zentaris Inc Description and Business Overview
    Table 56. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 57. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Product
    Table 58. Aeterna Zentaris Inc Recent Developments/Updates
    Table 59. Aphios Corp Corporation Information
    Table 60. Aphios Corp Description and Business Overview
    Table 61. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 62. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Product
    Table 63. Aphios Corp Recent Developments/Updates
    Table 64. Incyte Corp Corporation Information
    Table 65. Incyte Corp Description and Business Overview
    Table 66. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 67. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Product
    Table 68. Incyte Corp Recent Developments/Updates
    Table 69. Lakewood-Amedex Inc Corporation Information
    Table 70. Lakewood-Amedex Inc Description and Business Overview
    Table 71. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 72. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Product
    Table 73. Lakewood-Amedex Inc Recent Developments/Updates
    Table 74. Novartis AG Corporation Information
    Table 75. Novartis AG Description and Business Overview
    Table 76. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 77. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Product
    Table 78. Novartis AG Recent Developments/Updates
    Table 79. Obexia AG Corporation Information
    Table 80. Obexia AG Description and Business Overview
    Table 81. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 82. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Product
    Table 83. Obexia AG Recent Developments/Updates
    Table 84. PsiOxus Therapeutics Ltd Corporation Information
    Table 85. PsiOxus Therapeutics Ltd Description and Business Overview
    Table 86. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 87. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Product
    Table 88. PsiOxus Therapeutics Ltd Recent Developments/Updates
    Table 89. RaQualia Pharma Inc Corporation Information
    Table 90. RaQualia Pharma Inc Description and Business Overview
    Table 91. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 92. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Product
    Table 93. RaQualia Pharma Inc Recent Developments/Updates
    Table 94. Viking Therapeutics Inc Corporation Information
    Table 95. Viking Therapeutics Inc Description and Business Overview
    Table 96. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 97. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Product
    Table 98. Viking Therapeutics Inc Recent Developments/Updates
    Table 99. Production Base and Market Concentration Rate of Raw Material
    Table 100. Key Suppliers of Raw Materials
    Table 101. Cancer Anorexia-Cachexia Syndrome Drug Distributors List
    Table 102. Cancer Anorexia-Cachexia Syndrome Drug Customers List
    Table 103. Cancer Anorexia-Cachexia Syndrome Drug Market Trends
    Table 104. Cancer Anorexia-Cachexia Syndrome Drug Market Drivers
    Table 105. Cancer Anorexia-Cachexia Syndrome Drug Market Challenges
    Table 106. Cancer Anorexia-Cachexia Syndrome Drug Market Restraints
    Table 107. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 108. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share Forecast by Type (2023-2028)
    Table 109. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 110. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share Forecast by Type (2023-2028)
    Table 111. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 112. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share Forecast by Application (2023-2028)
    Table 113. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 114. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share Forecast by Application (2023-2028)
    Table 115. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 116. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share Forecast by Region (2023-2028)
    Table 117. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 118. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share Forecast by Region (2023-2028)
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Cancer Anorexia-Cachexia Syndrome Drug
    Figure 2. Global Cancer Anorexia-Cachexia Syndrome Drug Market Share by Type in 2021 & 2028
    Figure 3. NEO-1940 Product Picture
    Figure 4. C-1889 Product Picture
    Figure 5. DLN-101 Product Picture
    Figure 6. Foxo1-nRNA Product Picture
    Figure 7. AVGN-7 Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Cancer Anorexia-Cachexia Syndrome Drug Market Share by Application in 2021 & 2028
    Figure 10. Hospital
    Figure 11. Clinic
    Figure 12. Others
    Figure 13. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size (2017-2028) & (US$ Million)
    Figure 15. Global Cancer Anorexia-Cachexia Syndrome Drug Sales (2017-2028) & (K Pcs)
    Figure 16. Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Manufacturers in 2021
    Figure 17. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Manufacturers in 2021
    Figure 18. The Global 5 and 10 Largest Cancer Anorexia-Cachexia Syndrome Drug Players: Market Share by Revenue in 2021
    Figure 19. Cancer Anorexia-Cachexia Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 20. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2017-2022)
    Figure 21. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region in 2021
    Figure 22. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region (2017-2022)
    Figure 23. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region in 2021
    Figure 24. U.S. Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Canada Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Germany Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. France Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. U.K. Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Italy Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Russia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. China Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Japan Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. South Korea Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. India Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Australia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Taiwan Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Indonesia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Thailand Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Malaysia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Philippines Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Vietnam Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Mexico Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Brazil Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Argentina Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Turkey Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Saudi Arabia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. UAE Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 48. Sales Market Share of Cancer Anorexia-Cachexia Syndrome Drug by Type (2017-2022)
    Figure 49. Manufacturing Cost Structure of Cancer Anorexia-Cachexia Syndrome Drug
    Figure 50. Manufacturing Process Analysis of Cancer Anorexia-Cachexia Syndrome Drug
    Figure 51. Cancer Anorexia-Cachexia Syndrome Drug Industrial Chain Analysis
    Figure 52. Channels of Distribution
    Figure 53. Distributors Profiles
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Acacia Pharma Ltd
Aeterna Zentaris Inc
Aphios Corp
Incyte Corp
Lakewood-Amedex Inc
Novartis AG
Obexia AG
PsiOxus Therapeutics Ltd
RaQualia Pharma Inc
Viking Therapeutics Inc
Frequently Asked Questions
Cancer Anorexia-Cachexia Syndrome Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cancer Anorexia-Cachexia Syndrome Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cancer Anorexia-Cachexia Syndrome Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

CD40 Ligand

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More